EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS155-05275 
Organism
Homo sapiens 
Tissue/cell
Ovary 
Coordinate
chr16:16092250-16092820 
TF binding sites/motifs
Number: 7             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr16:16092427-16092445TCGTCATGCCTTCCTTCC-6.13
EWSR1-FLI1MA0149.1chr16:16092435-16092453CCTTCCTTCCCTTCCTTC-6.33
EWSR1-FLI1MA0149.1chr16:16092431-16092449CATGCCTTCCTTCCCTTC-6.4
GATA2MA0036.3chr16:16092677-16092688TTCTTATCTCT+6.32
Gata1MA0035.3chr16:16092677-16092688TTCTTATCTCT+6.32
ZNF263MA0528.1chr16:16092441-16092462TTCCCTTCCTTCTGCTCCCTC-6.2
ZNF263MA0528.1chr16:16092438-16092459TCCTTCCCTTCCTTCTGCTCC-6.73
Number of super-enhancer constituents: 8             
IDCoordinateTissue/cell
SE_13655chr16:16090000-16093610CD34_Primary_RO01536
SE_26926chr16:16091864-16092861Esophagus
SE_32168chr16:16091064-16092831Gastric
SE_38584chr16:16087626-16093828HUVEC
SE_39016chr16:16090023-16092976IMR90
SE_44900chr16:16089971-16093209NHLF
SE_47158chr16:16079860-16093268Panc1
SE_48435chr16:16090000-16093577Psoas_Muscle
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr161609229416092782
Number: 1             
IDChromosomeStartEnd
GH16I015992chr161608647416095067
Enhancer Sequence
TGGGTTTACA GGCGTGAGCC ACTGTGCCCG GTCCTCAGAT GATCTTAGCT TTGTGACCTA 60
TGCTGTTGGC CGCTGTAGGG GCTGTGATGG AGGTGATGTG GGGGTGGATG GCAGGGGTGA 120
CCCGTGTTGG CTGCTTTCTG TAACAGTCAT AGTTCATGGT CAGAGTCAGA TTTCCTCTCG 180
TCATGCCTTC CTTCCCTTCC TTCTGCTCCC TCCCACAGCC GCCCTTTGGG TCTGGGCTGG 240
CCATCTGGCT CTGAGCAGGA AGCTAGCCTG TGCTCTTCAA TTTGCTTTCT GCAGGGGAAA 300
CACCTTCCTT TGCTCAGCGT TTCCTGACCT CTCCTTCCCT GGAGTTCCGG TGTCCTTAAA 360
TGCTCTCTGG TTTCTTCTGT AGCTTACTTT CTTGCTTGAA AGGACAACTT TTCTTTGTCC 420
TTTAGACTTC TTATCTCTGG GCAATACAGT GGTGGTGGCA GTGGTGATTA TTATCAACTA 480
TTAGTATCTG CTACTACGGT TTATTGTCTC TAGACTGTAT CAGCACCTGT CACACATTGT 540
CCCATTGAAT CCTCTCCAGA ACTCTTCCAA 570